Home-based Heart Monitoring Now Available to All Canadians Through Icentia

Home-based Heart Monitoring Now Available to All Canadians Through Icentia

QUEBEC CITY, Jan. 19, 2021 (GLOBE NEWSWIRE) — Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac test from the safety of their homes while the pandemic surges on.
Icentia enables at-home tests through its CardioSTAT® device, a Canadian designed and manufactured, proven alternative to traditional Holter monitor tests. Since its introduction in 2015, the CardioSTAT test has become the tool of choice for hundreds of physicians across Canada and the United Kingdom for the detection of heart rhythm disorders. This inventive and life-saving solution is now being implemented nationally for at-home tests in much needed times.As the pandemic rages on, wait times in the Canadian healthcare system are becoming a serious issue. Backlogs for all procedures, including ECG monitoring, continue to grow. Social distancing and contamination risk requirements have increased the burden on hospitals and clinics, bolstering the demand for home-based tests. “The pandemic is forcing our healthcare system to evolve and adapt. This smart and accurate cardiac monitoring technology is what Canadians need right now to stay safe and keep healthy,” explains Dr. Marko Mrkobrada, Internist, London Health Sciences Centre, London, ON.This new home-based solution, where no visit to health care facility for hook up or device return is required, promises to lighten the load on medical staff while also increasing safety for all. “We are glad to relieve some of the pressure on our healthcare system and to contribute to more safety through our home-based, patient-initiated tests. CardioSTAT test, which has proven to be easy to use, reliable and safe over the past years, makes even more sense in today’s context,” says Icentia CEO Pierre Paquet.About CardioSTATThe CardioSTAT test relies on a unique single-use electrocardiography monitoring device designed to be comfortably worn on the upper chest for up to 14 days. It has the potential to reduce lead times to diagnosis, while providing the patient with a greatly improved experience. Quick and easy to install, it avoids the inconvenience and discomfort caused by multiple skin adhesive electrodes wired to Holter monitors. The result is a highly efficient, yet comfortable and very discrete, wire-free cardiac monitor that does not restrict patients from showering or doing physical activity. Upon complete analysis of the recording by Icentia, results are reviewed by a certified cardiologist before being reported to the patient’s prescribing doctor. For more information, visit cardiostat.com.About IcentiaBased in Canada, Icentia is a combined medical device and service company. Icentia pioneers innovative solutions for healthcare institutions in the field of medical testing. Icentia aims to help healthcare institutions in becoming more efficient while providing patients with the ease, comfort, peace of mind and safety of reliable at-home medical monitoring through technological advances. For more information, visit icentia.com.Icentia Inc.
1 800 431 9148


CBJ Newsmakers

Recommended
PureK Holdings Corp’s Leading All-Natural PureKana Brand Now Available at CBD EmporiumSonoro Announces Final Assay Results From 2020 Drilling Program